A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 414 participants.

Also called NCT02268929

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 414 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02268929
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02268929. Randomized; no masking; primary purpose diagnostic. Start 2014-10-14 (actual); primary completion 2017-01-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.
Acronym
PDM-ProValueGP
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
Accu-Chek Smart Pix Software
Intervention (Device)
Accu-Chek Smart Pix readout Device
Lead sponsor
Hoffmann-La Roche (class: industry)
Collaborator
Roche Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct02268929
Content hash
4e97994afd71e8a318d89216cee01c6bc25a818cddec659393f63e0e39c4c1d5